SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear
Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene editing could cure sickle cell and thalassemia in new trial
⭐️ CURE ⭐️ Recruiting nowThis early-stage trial tests a gene-editing treatment for people with severe sickle cell disease or beta-thalassemia. The approach uses the patient's own blood stem cells, which are edited to boost fetal hemoglobin—a healthy type that can replace the defective hemoglobin. Up to 1…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: PHASE1 • Sponsor: Daniel Bauer • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
Sickle cell kidney hope: common diabetes drug tested to save kidneys
Disease control Recruiting nowThis study tests whether empagliflozin, a drug already approved for kidney disease in diabetes, can slow kidney damage in people with sickle cell anemia. About 20 adults with sickle cell disease and early signs of kidney trouble will take the drug for 6 months. Researchers will m…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC